Investor Ideas, Trading Ideas and Stocks to Watch

Friday, February 10, 2023

#AIEye #Podcast 756: #AI #Stocks discussed: (NYSE: $GLOB) (NYSE: $ZETA)

#AIEye #Podcast 756: #AI #Stocks discussed: (NYSE: $GLOB) (NYSE: $ZETA)

Globant Announces Update to AI Platform GeneXus, and Zeta Introduces Beta Launch of ChatBotZeta

Global #AI in #Healthcare Market to Reach $95.65B by 2028

Vancouver, Kelowna, Delta, BC – February 10, 2023 – Investorideas.com, a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence

Today’s podcast is sponsored by Fintech Company AppTech Payments Corp. (NasdaqCM:APCX).

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2023/021023-AI-Eye.mp3

Read this in full at https://www.investorideas.com/news/2023/artificial-intelligence/02101GLOB-ZETA.asp

Hear the Ai Eye on Spotify

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NYSE:GLOB) (NYSE:ZETA)

Globant S.A. (NYSE:GLOB) has announced a major update to its AI-powered Low Code platform, GeneXus. Specifically, the company has combined deterministic symbolic AI with LLM (Large Language Model) technology, enabling GeneXus Next to “create and maintain unprecedented enterprise software solutions in record time.” Martin Migoya, Co-Founder and CEO of Globant, said:

"Globant has been at the forefront of the AI industry for the past decade. With GeneXus Next we continue to revolutionize our industry, making it easier for companies to build digital products and reinvent their businesses for sustained growth."

Nicolás Jodal, CEO of GeneXus, commented:

"In the past, GeneXus has utilized symbolic AI to create mission-critical systems with exceptional user experiences and quality. Now, the combination of symbolic models and foundation models like GPT-3 will further speed up and simplify the development process, enabling businesses to bring value to end-users faster than ever before.”

Zeta Global Holdings Corp. (NYSE:ZETA) has introduced the beta launch of ChatBotZeta, described as “a product that reads and synthesizes trillions of consumer signals from Zeta’s proprietary Data Cloud with generative artificial intelligence (AI) to produce conversational attributes and descriptions of individuals.” According to the press release, ChatBotZeta “is being built to enhance the ZMP’s AI models and handle several processes automatically, with the goal of producing more personalized consumer experiences that impact brand growth.” David A. Steinberg, Co-Founder, Chairman, and CEO of Zeta, explained:

"Zeta has a long history of leading the marketing technology industry with AI at the core of our platform. Integrating more disruptive generative language model technology is another step toward our vision of making sophisticated marketing simple for enterprise brands. With generative models like ChatBotZeta, the ZMP’s data discovery tools will be sharper, intent-based scoring will be enhanced, and most importantly, our customers will be further empowered to drive even greater results for their business."

Global AI in Healthcare Market to Reach $95.65B by 2028

A report published by Vantage Market Research finds that the global market for AI in Healthcare is projected to grow from $6.6 billion USD in 2021 to $95.65 billion by 2028, registering a compound annual growth rate (CAGR) of 46.1 percent in the forecast period 2022-28. The following excerpt from the report’s description outlines some key factors impacting the market’s growth:

The use of AI in healthcare is at a nascent stage, but it has the potential to revolutionize the industry. Artificial intelligence can potentially lead to $150 billion annual savings for the US economy and could help create up to 400,000 new jobs by 2035. This market is estimated at $6 billion and growing rapidly because there is an increased demand for machine learning solutions in healthcare settings. Research indicates that more than 80 percent of patients would like their physicians or other healthcare professionals to make data-driven decisions that improve their outcomes as well as enhance patient satisfaction.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here

Podcast sponsor:

AppTech Payments Corp. (NasdaqCM:APCX) is an innovative Fintech company whose mission is to deliver a better way for businesses to provide their customers with immersive commerce experiences. Commerse™, its all-new, patent-backed technology platform powering seamless omni-channel Commerce Experiences-as-a-Service (CXS), drives highly secure, scalable, cross-border digital banking, text-to-pay, crypto payments and merchant services altogether from a single, unified stack designed to increase operational efficiencies and growth for businesses while providing the economic convenience that their customers demand from today’s commerce experiences. For more information, visit apptechcorp.com.

About Investorideas.com - Big Investing Ideas

We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water.

The Investorideas.com podcasts are also available on Apple Podcasts , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Disclosure: APCX is a paid featured fintech stock on Investorideas.com

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com

Contact Investorideas.com

800 665 0411

Get more Technology stock investor ideas - news, articles, podcasts and stock directories

New #Stocks and #TradingIdeas (Nasdaq: $LIFE) (Nasdaq: $LSTA) (TSXV: $CDX.V) (Nasdaq: $REUN) (CSE: $LIM.C) (TSXV: $FUSE.V)

New #Stocks and #TradingIdeas (Nasdaq: $LIFE) (Nasdaq: $LSTA) (TSXV: $CDX.V) (Nasdaq: $REUN) (CSE: $LIM.C) (TSXV: $FUSE.V)

#Biotech, #Psychedelics, #EVMetals and #Mining Stocks Added to Investor Ideas Free Stock Directories

Vancouver, Kelowna, Delta, BC, February 10, 2023 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Biotech, Psychedelics, EV Metals and Mining. Today’s stocks have been added to our lists of free stock directories in each sector.

Read this in full at https://www.investorideas.com/news/2023/main/02101Stocks.asp

The newest biotech companies include those involved in pharmaceuticals, biotherapeutics and digital healthcare.

The latest psychedelics company is developing therapies for patients suffering from postpartum depression and other mental health conditions.

The newest EV company is developing technologies for use in next generation batteries, while the latest mining company is exploring for metals for the manufacturing of batteries.

New Stocks added to the Biotech Stocks List:

Orexo AB (OTCQX: ORXOY; Nasdaq STO: ORX) develops improved pharmaceuticals and digital therapies addressing unmet needs within the growing space of substance use disorders and mental health. The products are commercialized by Orexo in the US or via partners worldwide. The main market today is the American market for buprenorphine/naloxone products, where Orexo commercializes its lead product ZUBSOLV® for treatment of opioid use disorder. Total net sales for 2021 amounted to SEK 565 million and the number of employees was 121. Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) and is available as ADRs on OTCQX (ORXOY) in the US. The company is headquartered in Uppsala, Sweden, where research and development activities are performed.

aTyr Pharma, Inc. (Nasdaq: LIFE) is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. aTyr’s research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets. aTyr’s primary focus is efzofitimod, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to downregulate immune engagement in fibrotic lung disease.

Lisata Therapeutics (Nasdaq: LSTA) is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Lisata’s lead investigational product candidate, LSTA1 (formerly known as CEND-1), is designed to modify the tumor microenvironment by activating a novel uptake pathway that allows anti-cancer drugs to penetrate solid tumors more effectively. LSTA1 actuates an active transport system in a tumor-specific manner, resulting in systemically co-administered anti-cancer drugs more efficiently penetrating and accumulating in the tumor, while normal tissues are not affected. LSTA1 has demonstrated favorable safety, tolerability, and activity in clinical trials to enhance delivery of standard-of-care chemotherapy for pancreatic cancer. Lisata and its collaborators have also amassed significant non-clinical data demonstrating enhanced delivery of a range of emerging anti-cancer therapies, including immunotherapies and RNA-based therapeutics. Lisata is exploring the potential of LSTA1 to enable a variety of treatment modalities to treat a range of solid tumors more effectively. In addition, Lisata also has clinical development programs based on its autologous CD34+ cell therapy technology platform.

Cloud DX Inc.(OTCQB: CDXFF; TSX-V: CDX) Accelerating digital healthcare, Cloud DX is on a mission to make healthcare better for everyone. Our Connected Health™ remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable aging in place, and deliver hospital-quality post-surgical care in the home. Our partners achieve better healthcare and patient outcomes, reduce the need for hospitalization or re-admission, and reduce healthcare delivery costs through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, 2022 Top Innovator by Canadian Business, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist, and one of "Canada's Ten Most Prominent Telehealth Providers." Cloud DX is an exclusive partner to Medtronic Canada, Teladoc Health Canada, and Equitable Life of Canada.

HealthBeacon PLC (OTCQX: HBCNF; Euronext Dublin: HBCN) is an Irish digital therapeutics company that develops products for managing injectable medications for patients in the home. The HealthBeacon Injection Care Management System tracks adherence and persistence with medication schedules through the provision of medication management reminders, safe and sustainable sharps disposal devices, educational tools, and artificial intelligence (AI) driven data analytics. The Company operates across Europe, North America and the United Kingdom and employs more than 70 people and has obtained more than 30 design and utility patents. Peer reviewed evidence supports a 19% improvement in therapy persistence by patients and up to 26% improvement in adherence to therapy, which improves clinical outcomes and significantly improves efficiency in health systems. The Company’s mission is to become the world’s leading digital therapeutics platform for injectable medications.

New Stocks added to the Psychedelics Stocks List:

Reunion Neuroscience Inc. (Nasdaq: REUN) is committed to developing innovative therapeutic solutions for underserved mental health conditions. The Company’s lead asset, RE104, is a proprietary, novel serotonergic psychedelic compound being developed as a potential fast-acting and durable treatment for patients suffering from postpartum depression and other mental health conditions. RE104 is protected under US Patent No. 11,292,765 issued on April 5, 2022 (priority June 30, 2020) with claims for composition of matter, methods of manufacturing, formulations and methods of use for a genus of hemi-ester tryptamines, including RE104, which could provide protection out to June 30, 2041. Reunion is also developing the RE200 series, which includes compounds with potential for more selective serotonin receptor activity with reduced psychoactivity for potential use in more chronic treatment paradigms and indications.

New Stocks added to the EV Metals/Batteries Stocks List:

Li Metal Corp. (OTCPink: LIMFF; CSE: LIM) is a Canadian-based company developing lithium metal anodes and lithium metal production technologies for use in next generation batteries. Our production methods are significantly more sustainable than existing products and offer lighter, more energy dense and safer batteries that are critical to tomorrow’s electric vehicles.

New Stocks added to the Mining Stocks List:

Fuse Battery Metals Inc. (TSXV:FUSE) Formerly Fuse Cobalt - focus is on exploration for high value metals required for the manufacturing of batteries.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - Big Investing Ideas

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

Contact Investorideas.com

800 665 0411

Thursday, February 09, 2023

#ExploringMining #Podcast 327 - News from #MiningStocks (NYSE: $GOLD) (NYSE: $MT) (TSXV: $RYR.V) (CSE: $KUYA.C)

#ExploringMining #Podcast 327 - News from #MiningStocks (NYSE: $GOLD) (NYSE: $MT) (TSXV: $RYR.V) (CSE: $KUYA.C)

Vancouver, Kelowna, Delta, BC, February 9, 2023 Investorideas.com, a global investor news source covering mining and metals stocks releases today’s edition of Exploring Mining Podcast, featuring stock news from TSX, TSXV ,CSE, ASX, NASDAQ, NYSE companies plus interviews with CEO's and leading experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2023/020923-Mining.mp3

Read this in full at https://www.investorideas.com/news/2023/exploring-mining/02091GOLD-MT-RYR-KUYA.asp

Listen to Exploring Mining podcast on iTunes Apple podcasts

Listen to Exploring Mining on Spotify

Barrick Gold Corporation (NYSE:GOLD) has reported on its 2022 gold reserve growth. The company, according to the press release, “grew attributable proven and probable gold mineral reserves by 6.7 million ounces net of depletion in 2022.” Barrick’s President and CEO, Mark Bristow, said:

“While we continue to evaluate all new opportunities against our strategic filters, we have always believed that finding our ounces is better than buying them, and this year’s resource and reserve statement showcases the unmatched potential of our organic growth pipeline.”

ArcelorMittal (NYSE:MT) has announced its results for the three-month and twelve-month periods ended December 31, 2022. Highlights include a FY 2022 operating income of $10.3 billion, as well as the generation of $6.4 billion in free cash flow for the year. Aditya Mittal, the company’s CEO, said:

“Despite the challenges that emerged as the year unfolded, our full year results demonstrate the benefits of our strengthened asset portfolio and the improvements we have made to our cost base in recent periods. This, alongside the mitigatory actions we took in the second half of the year to adapt production levels and optimize energy consumption, has added resilience to our business.”

Royal Road Minerals Limited (TSXV:RYR) has entered into a Strategic Alliance Agreement and a Non-Binding Letter of Intent with investment holding company MSB Holdings Limited pertaining to copper, gold and other metals exploration in the Kingdom of Saudi Arabia (KSA). This will see Royal Road and MSB form an alliance “aimed at developing an exploration decision-support-system, leading to the development of priority targets and an initial 12-month work program and budget for exploration operations in the "Arabian Shield" area of the KSA.” Tim Coughlin, Royal Road's President and CEO, explained:

"The Arabian Shield is one of the most prospective and underexplored regions in the world, with outstanding potential for world-class copper and gold resources. The Kingdom of Saudi Arabia is an impressively proactive and supportive host-country which, through its Vision 2030 initiative, is actively promoting responsible mining and mining investment and is committed to sustainably developing its mineral resources and playing a key role in the supply of critical metals.”

Kuya Silver Corporation (CSE:KUYA) has announced an agreement with Minera Perú Sol S.A.C. to process mineralized material from the Bethania Project in Peru. David Stein, Kuya Silver's President and CEO, said:

"This toll milling agreement will allow Kuya to begin processing material from the Bethania Project to produce silver-lead and zinc concentrates in 2023, similar to how the mine has operated in the recent past. We are delighted to have this option available to start ramping up production when we are ready, which greatly increases our flexibility as we look to restart the Bethania mine. The knowledge gained from this initial processing step should be useful in reducing operational risks as we look to develop our own plant at site."

The Investorideas.com podcasts are also available on Apple Podcasts , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Research mining stocks at Investorideas.com with our mining stocks directory at Investorideas.com https://www.investorideas.com/Gold_Stocks/Stocks_List.asp

About Investorideas.com - Big Investing Ideas

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com to be a guest or sponsor this podcast

800-665-0411

Get more mining stock investor ideas- news, articles, podcasts and stock directories

#ChatGPT Buzz and #AI #Stocks to Watch (OTCPINK: $GTCH) (NYSE: $AI) (NYSE: $BBAI) (NASDAQ: $SOUN) @C3_AI @bigbearai @SoundHound

#ChatGPT Buzz and #AI #Stocks to Watch (OTCPINK: $GTCH) (NYSE: $AI) (NYSE: $BBAI) (NASDAQ: $SOUN) @C3_AI @bigbearai @SoundHound

Vancouver, Kelowna, Delta, BC –– February 9, 2023 Investorideas.com, a global investor news source covering Artificial Intelligence and tech stocks releases a sector snapshot featuring GBT Technologies Inc. (OTCPINK:GTCH) and its Avant! AI machine learning system.

Read this article, featuring GTCH in full at https://www.investorideas.com/news/2023/technology/02091ChatGPT-GTCH-AI-BBAI-SOUN.asp

AI stocks including Shares of C3.ai, Inc. (NYSE: AI), BigBear.ai Holdings, Inc. (NYSE: BBAI) and SoundHound AI (NASDAQ: SOUN) have rallied recently due to the excitement of OpenAI's ChatGPT, as investors look for the next big thing in AI.

For a list of AI stocks on Investorideas.com to research visit:

https://www.investorideas.com/TSS/stock_list.asp#Robotics

According to GBT Technologies (OTCPINK:GTCH), “It has been almost five years since Avant! AI was introduced. Since then, AI technologies have gained vast interest in a wide variety of topics. For example, text-generation models like chatGPT has garnered a lot of attention for its ability to create text that looks and sounds like it was written by a human. Now it’s looking like the next iteration of the software, GPT-4, is just around the corner, with an estimated release date of sometime in early 2023.”

“Avant!-AI is a text-generation, deep learning, self-training model that is working based on an innovative, unique concept. Not like other similar models, for example chatGPT, it learns on its own and is constantly enhancing its information database. Avant!-AI’s main advantage is the fact that it includes unsupervised learning capabilities.”

CTO Danny Rittman says, “The goal of Avant!-AI is to perform tasks that typically require human intelligence, such as perception, analysis, reasoning, and decision-making. “

The Hippocrates system for Diagnostics https://www.hmd.care, is GBT Technologies Avant! health application. The Hippocrates health system is an AI-based medical advisor. Users may provide symptoms, ask medical questions and describe conditions in order to get diagnosis advise, including known medication and treatments.

BigBear.ai Holdings, Inc. (NYSE: BBAI) says on its website (https://bigbear.ai) “As a leader in the use of Artificial Intelligence (AI) and Machine Learning (ML), we are making AI-powered decision support accessible and scalable for any organization.”

BigBear.ai delivers AI-powered analytics and cyber engineering solutions to support mission-critical operations and decision-making in complex, real-world environments. BigBear.ai’s customers, which include the US Intelligence Community, as well as customers in manufacturing, logistics, commercial space, and other sectors, rely on BigBear.ai’s solutions to see and shape their world through reliable, predictive insights and goal-oriented advice.

The Company just announced a $25 Million private placement to move forward with its mission.

SoundHound AI (NASDAQ: SOUN) also announced funding recently, reporting it had closed $25 million in preferred equity financing.

From the news: “Additionally, SoundHound pre-announces strong preliminary 2022 results with revenue of approximately $31 million, at the high-end of its prior guidance, and gross margins in excess of 70%1. The Company expects revenue growth in 2023 to accelerate to approximately 50% year-over-year due to its strong customer base, well over $300 million bookings foundation, and increasing demand for its voice AI-enabled customer service products. Full year 2022 results and 2023 formal guidance will be released with the company’s upcoming earnings announcement.”

SoundHound AI offers an independent voice AI platform that enables businesses across industries to deliver best-in-class conversational experiences to their customers. Built on proprietary Speech-to-Meaning® and Deep Meaning Understanding® technologies, SoundHound’s advanced voice AI platform provides exceptional speed and accuracy and enables humans to interact with products and services like they interact with each other-by speaking naturally.

The founders of OpenAI's ChatGPT say on their site that their “mission is to ensure that artificial general intelligence (AGI)-by which we mean highly autonomous systems that outperform humans at most economically valuable work-benefits all of humanity.”

“We will attempt to directly build safe and beneficial AGI, but will also consider our mission fulfilled if our work aids others to achieve this outcome.”

Only time will tell how AI technology will play a role in our lives and to what extent-let’s hope it is friendly to us humans along the way.

Danny Rittman, CTO of GBT Technologies Inc. told Investor Ideas, “The question of whether AI will replace humans is a complex one that depends on many factors. While it is true that AI will automate many tasks, it is also likely that it will create new opportunities and augment human capabilities. Our Avant!-AI does not aim to replace humans, but to become an efficient assistant and advisor. Its cognitive and reasoning capabilities could make it a welcomed additional member to a team workforce. GBT will continue its research and development in this field to ensure that the benefits of AI technology are widely shared and that its negative consequences are mitigated through appropriate policies and regulations.”

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye Podcast.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp Disclosure: GTCH is a paid featured monthly AI stock on Investorideas.com

Contact Investorideas.com

800 665 0411

Get more Technology stock investor ideas - news, articles, podcasts and stock directories

About Investorideas.com

About Investorideas.com - Big Investing Ideas Investorideas.com is a platform for investing ideas. We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.

Disclaimer/disclosure

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas, Trading Ideas and Stocks to Watch

Friday, February 10, 2023

#AIEye #Podcast 756: #AI #Stocks discussed: (NYSE: $GLOB) (NYSE: $ZETA)

New #Stocks and #TradingIdeas (Nasdaq: $LIFE) (Nasdaq: $LSTA) (TSXV: $CDX.V) (Nasdaq: $REUN) (CSE: $LIM.C) (TSXV: $FUSE.V)

Thursday, February 09, 2023

#ExploringMining #Podcast 327 - News from #MiningStocks (NYSE: $GOLD) (NYSE: $MT) (TSXV: $RYR.V) (CSE: $KUYA.C)

#ChatGPT Buzz and #AI #Stocks to Watch (OTCPINK: $GTCH) (NYSE: $AI) (NYSE: $BBAI) (NASDAQ: $SOUN) @C3_AI @bigbearai @SoundHound

Blog Archive

Links

Search This Blog